Up 200% MDQK.HM MediNavi AG (HAM) 12 Mar 2026: watch liquidity, forecast

MDQK.HM stock surged 200.00% to €7.50 on 12 Mar 2026 during market hours on the HAM exchange in Germany, driven by a move from an open of €2.50 to a day high of €7.50. The jump came on a tiny reported volume of 35 shares versus an average volume of 41, so price action reflects low liquidity more than broad demand. Traders should note thin trading, missing EPS and no recent earnings announcement, which raises execution and valuation risk even as the bounce tests the 50-day average at €2.50

MDQK.HM stock: intraday price action and volume

Today MediNavi AG (MDQK.HM) opened at €2.50 and reached €7.50, a €5.00 change and 200.00% intraday gain on the HAM exchange in Germany. Reported volume was 35 versus an average of 41, so the move occurred on extremely thin liquidity. The day low of €2.50 equals the open and the year low is €1.50, which highlights how sporadic trading can create outsized percentage moves.

MDQK.HM stock technicals and key metrics

MDQK.HM shows a 50-day average price of €2.50 and a 200-day average of €2.00, with an ATR of 5.00, reflecting high intraday range. There is no EPS or P/E reported, and price-to-sales and price-to-book metrics are not meaningful. Enterprise value is listed as -€255,031.00 and EV/EBITDA is 2.17, but several balance-sheet fields are incomplete, making classic valuation ratios unreliable for a precise fair-value estimate.

MDQK.HM stock fundamentals and sector context

MediNavi AG operates in Healthcare, specifically Medical – Healthcare Information Services, with headquarters in Munich and website MediNavi. The German healthcare sector average P/E is near 29.67, but many sector peers have deeper liquidity and regular earnings. MediNavi’s public metrics show a high current ratio of 41.50, working capital of €269,922.60, and negative returns on capital, reflecting a small-cap profile and limited trading history.

Meyka AI rating and analyst-style verdict for MDQK.HM stock

Meyka AI rates MDQK.HM with a score out of 100: 62.67 / B — HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The simple takeaway: limited liquidity and patchy public data keep risk elevated even after a sharp intraday rally, supporting a Hold stance for risk-managed portfolios.

MDQK.HM stock risks and trading considerations

Key risks include missing EPS and no scheduled earnings announcement, unknown shares outstanding, and near-zero market cap reporting. Thin volume causes high volatility and rapid price swings, creating execution risk and wide bid-ask spreads. Short-term traders can profit from momentum, but position sizing and stop rules are essential because a few trades move price substantially.

MDQK.HM stock opportunities and price targets

Opportunities are speculative: a liquidity-driven breakout could attract follow-through if news or listing developments occur. For planning, we provide layered price targets: conservative €4.50, base €6.50, and upside €10.00 as a stretch scenario. These targets are scenario-based, not firm recommendations, and assume clearer liquidity or corporate updates.

Final Thoughts

MDQK.HM stock’s €7.50 close on 12 Mar 2026 reflects a dramatic intraday move on extremely low volume, so price alone overstates market interest. Short-term traders may find momentum opportunities, while longer-term investors face opaque fundamentals: no EPS, no reliable market-cap data and limited analyst coverage. Meyka AI’s forecast model projects a 12-month price of €5.00, versus the current €7.50, implying a downside of -33.33%. This forecast is model-based and not a guarantee; use it as one input in a disciplined risk plan. For now, Meyka AI’s B grade and HOLD suggestion reflect thin liquidity, incomplete financials and high volatility. Investors planning exposure should size positions carefully, watch for corporate updates on MediNavi, and monitor daily volume to confirm whether today’s move signals lasting interest or a short-lived spike.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.